MYOK: MyoKardia, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

MyoKardia, Inc.

NASDAQ:MYOK

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$224.91
Loss Chance
54.3%
2.06JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Innoviva
NASDAQ:INVA
5.41
$23.55
33.61%
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
5.18
$230.25
38.22%
Merck & Co.
NYSE:MRK
6.36
$119.60
51.93%
Viatris
NASDAQ:MYL
4.21
$15.86
63.45%
Prestige Consumer Healthcare
NYSE:PBH
4.85
$46.05
23.82%
Jitta Factors
Growth Opportunity (16)
Recent Business Performance (19)
Financial Strength (58)
Return to Shareholders (0)
Competitive Advantage (25)
Jitta Signs
Operating MarginInconsistent
Recent Business PerformanceEarning decline 308.01% in the last year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.06
100.00%
3.05
215.73%
3.05
149.75%
Pharmaceuticals
5.41
33.61%
5.18
38.22%
6.36
51.93%
COMPANY DESCRIPTION
MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is Mavacamten, an orally administered allosteric modulator of cardiac myosin, which is in Phase III clinical trial for the treatment of hypertrophic cardiomyopathy (HCM). The company also develops Danicamtiv, an orally administered small molecule, which completed Phase I and Phase IIa clinical trials on patients with dilated cardiomyopathy. Its preclinical programs include MYK-224, a small molecule program for the treatment of HCM targeting hypercontractility and impaired relaxation; ACT-1 for the treatment of diastolic dysfunction; and LUS-1 for the treatment of diastolic dysfunction. Myokardia, Inc. was founded in 2012 and is headquartered in Brisbane, California. As of November 16, 2020, MyoKardia, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
www.myokardia.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.